Sangamo Therapeutics (SGMOQ) Shares Outstanding (Entity) (2010 - 2025)
Analysis
Sangamo Therapeutics (SGMOQ) Shares Outstanding (Entity) (2010 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.09 Bn | 9.24 Bn | 112.79 Mn | 29.60 Mn |
| 2 | CRISPR Therapeutics AG | 5.22 Bn | 5.22 Bn | - | 96.66 Mn |
| 3 | Iovance Biotherapeutics | 3.90 Bn | 3.60 Bn | 55.72 Mn | 452.97 Mn |
| 4 | Legend Biotech | 3.67 Bn | 2.70 Bn | 251.50 Mn | - |
| 5 | uniQure | 3.10 Bn | 3.10 Bn | 5.49 Mn | 69.33 Mn |
| 6 | Beam Therapeutics | 2.69 Bn | 2.69 Bn | - | 103.26 Mn |
| 7 | Precigen | 2.43 Bn | 2.43 Bn | 52.17 Mn | 358.01 Mn |
| 8 | Sarepta Therapeutics | 2.35 Bn | 1.55 Bn | 251.87 Mn | 105.62 Mn |
| 9 | Vericel | 1.99 Bn | 1.82 Bn | 56.40 Mn | 51.17 Mn |
| 10 | Sangamo Therapeutics | 43.29 Mn | 22.34 Mn | - | 280.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 280.20 Mn |
| Sep 30, 2025 | 336.49 Mn |
| Jun 30, 2025 | 301.71 Mn |
| Mar 31, 2025 | 233.17 Mn |
| Dec 31, 2024 | 212.84 Mn |
| Sep 30, 2024 | 208.65 Mn |
| Jun 30, 2024 | 208.22 Mn |
| Mar 31, 2024 | 207.51 Mn |
| Dec 31, 2023 | 178.13 Mn |
| Sep 30, 2023 | 177.35 Mn |
| Jun 30, 2023 | 177.11 Mn |
| Mar 31, 2023 | 171.83 Mn |
| Dec 31, 2022 | 166.79 Mn |
| Sep 30, 2022 | 163.88 Mn |
| Jun 30, 2022 | 156.55 Mn |
| Mar 31, 2022 | 146.69 Mn |
| Dec 31, 2021 | 145.92 Mn |
| Sep 30, 2021 | 145.67 Mn |
| Jun 30, 2021 | 145.34 Mn |
| Mar 31, 2021 | 143.88 Mn |